Biblio Discovery — Demo Discovery Service

10 results for "Raynard, Bruno"

Showing 1–10 · 0.48 seconds · RSS

  1. Journal Article Full text

    The prevalence of CT-defined low skeletal muscle mass in patients with metastatic cancer: a cross-sectional multicenter French study (the SCAN study)

    Raynard, Bruno; Pigneur, Frederic; Di Palma, Mario et al.

    Support Care Cancer · 2021 · English · PubMed Central

    BACKGROUND: Cachexia, characterized by involuntary muscle mass loss, negatively impacts survival outcomes, treatment tolerability, and functionality in cancer patients. However, there is a limited appreciation of the true prevalence of low muscle mass due to inconsistent diagnostic methods and…

  2. Journal Article Full text

    Association between Nutritional Status and Treatment Response and Survival in Patients Treated with Immunotherapy for Lung Cancer: A Retrospective French Study

    Gouez, Manon; Delrieu, Lidia; Bouleuc, Carole et al.

    Cancers (Basel) · 2022 · English · PubMed Central

    SIMPLE SUMMARY: It is estimated that 73% of advanced non-small cell lung cancers (NSCLC) will become malnourished and develop cachexia which is considered as an independent prognostic factor. Therefore, this study aimed to investigate the association between nutritional assessments and (i)…

  3. Journal Article Full text

    In Reply: Randomized Studies Are Needed to Improve Knowledge of Nutritional Interventions for Advanced Cancer Patients

    Bouleuc, Carole; Marchal, Timothée; Chvetzoff, Gisèle et al.

    Oncologist · 2021 · English · PubMed Central

    This letter to the editor continues a discussion about parenteral nutrition for patients with advanced cancer and calls for future randomized studies assessing both enteral and parenteral nutrition.

  4. Journal Article Full text

    Psoas muscle index is not representative of skeletal muscle index for evaluating cancer sarcopenia

    Pigneur, Frédéric; Di Palma, Mario; Raynard, Bruno et al.

    J Cachexia Sarcopenia Muscle · 2023 · English · PubMed Central

    BACKGROUND: A common method for diagnosing sarcopenia involves estimating the muscle mass by computed tomography (CT) via measurements of the cross‐sectional muscle area (CSMA) of all muscles at the third lumbar vertebra (L3) level. Recently, single‐muscle measurements of the psoas major muscle at…

  5. Journal Article Full text

    Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?

    Deluche, Elise; Lachatre, Denis; Di Palma, Mario et al.

    Breast · 2021 · English · PubMed Central

    BACKGROUND: Sarcopenia has emerged as an important parameter to predict outcomes and treatment toxicity. However, limited data are available to assess sarcopenia prevalence in metastatic breast cancer and to evaluate its management. METHODS: The SCAN study was a cross-sectional multicenter French…

  6. Journal Article Full text

    Weight and skeletal muscle loss with cabozantinib in metastatic renal cell carcinoma

    Colomba, Emeline; Alves Costa Silva, Carolina; Le Teuff, Gwénaël et al.

    J Cachexia Sarcopenia Muscle · 2022 · English · PubMed Central

    BACKGROUND: Cabozantinib, a standard of care metastatic renal cell carcinoma (mRCC), may be associated with weight and muscle loss. These effects of new generation VEGFR tyrosine kinase inhibitor on muscle mass loss are poorly described. METHODS: All cabozantinib‐treated mRCC patients from January…

  7. Journal Article Full text

    Impact on Health‐Related Quality of Life of Parenteral Nutrition for Patients with Advanced Cancer Cachexia: Results from a Randomized Controlled Trial

    Bouleuc, Carole; Anota, Amélie; Cornet, Cécile et al.

    Oncologist · 2020 · English · PubMed Central

    BACKGROUND: Malnutrition worsens health‐related quality of life (HRQoL) and the prognosis of patients with advanced cancer. This study aimed to assess the clinical benefits of parenteral nutrition (PN) over oral feeding (OF) for patients with advanced cancer cachexia and without intestinal…

  8. Journal Article Full text

    Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening

    Hueso, Thomas; Ekpe, Kenneth; Mayeur, Camille et al.

    Gut Microbes · 2020 · English · PubMed Central

    Induction chemotherapy (7 + 3 regimen) remains the gold standard for patients with acute myeloid leukemia (AML) but is responsible for gut damage leading to several complications such as bloodstream infection (BSI). We aimed to investigate the impact of induction chemotherapy on the intestinal…

  9. Journal Article Full text

    A phase III randomized trial of weight loss to reduce cancer-related fatigue among overweight and obese breast cancer patients: MEDEA Study design

    Di Meglio, Antonio; Martin, Elise; Crane, Tracy E. et al.

    Trials · 2022 · English · PubMed Central

    BACKGROUND: Elevated body mass index (BMI) represents a risk factor for cancer-related fatigue (CRF). Weight loss interventions are feasible and safe in cancer survivors, leading to improved cardio-metabolic and quality of life (QOL) outcomes and modulating inflammatory biomarkers. Randomized data…

  10. Journal Article Full text

    Implementing a PROACTive Care Pathway to Empower and Support Survivors of Breast Cancer

    Franzoi, Maria Alice; Degousée, Lena; Martin, Elise et al.

    JCO Oncol Pract · 2023 · English · PubMed Central

    Optimal comprehensive survivorship care is insufficiently delivered. To increase patient empowerment and maximize the uptake of multidisciplinary supportive care strategies to serve all survivorship needs, we implemented a proactive survivorship care pathway for patients with early breast cancer at…